It was also reported that Src activity was markedly increased in trastuzumab resistant gastric cancer cells [53] and that activated Src was capable of interacting with and activating Stat3 in fibroblasts [54], implying that other signaling pathways may also be involved in development of trastuzumab resistance. Here, SRC is linked to gastric cancer.